होम › मल्टीपल मायलोमा › फ्लोरिडा › Miami
Miami, FL में मल्टीपल मायलोमा क्लिनिकल ट्रायल
Miami (लगभग 30 मील के भीतर) की साइटों पर मल्टीपल मायलोमा के लिए 21 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
भर्ती जारीचरण 1/2
- University of Miami, Miami
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
भर्ती जारीचरण 2
- University of Miami Sylvester Comprehensive Cancer Center, Miami
- University of Miami/Sylvester Cancer Institute - Alex's Place, Miami
- University of Miami/Sylvester Cancer Institute - Griffin Cancer Research Building, Miami
- और 2 अन्य
ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)
भर्ती जारीचरण 2
- University of Miami, Miami
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
भर्ती जारीचरण 3
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
भर्ती जारीचरण 3
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
- University of Miami Hospital and Clinics, Miami
- और 3 अन्य
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
भर्ती जारीचरण 3
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics, Miami
- Sylvester Comprehensive Cancer Center - Kendall, Miami
IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
भर्ती जारीचरण 2
- University of Miami, Miami
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
भर्ती जारीचरण 1
- University of Miami Don Soffer Clinical Research Center, Miami
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
भर्ती जारीचरण 1/2
- Research Site, Miami
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
भर्ती जारीचरण 1
- University of Miami, Miami
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
भर्ती जारीचरण 4
- Sylvester Comprehensive Cancer Center, Miami
- University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
- University of Miami Hospital and Clinics, Miami
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
भर्ती जारी
- University of Miami, Miami
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
भर्ती जारीअवलोकनात्मक अध्ययन
- University of Miami Hospitals, Miami
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
भर्ती जारीचरण 1/2
- University of Miami, Miami
- Miami Cancer Institute, Miami
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 2
- University of Miami, Miami
Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)
भर्ती जारीचरण 2
- University of Miami, Miami
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 2
- University of Miami, Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
भर्ती जारीअवलोकनात्मक अध्ययनस्वस्थ स्वयंसेवकों का स्वागत है
- Miami Cancer Institute, Miami
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
भर्ती जारीचरण 2
- University of Miami, Miami
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 1
- Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami
अन्य शहरों में मल्टीपल मायलोमा ट्रायल
- New York City, NY60 अध्ययन
- Boston, MA42 अध्ययन
- Atlanta, GA41 अध्ययन
- Houston, TX38 अध्ययन
- Durham, NC37 अध्ययन
- Nashville, TN32 अध्ययन
- Denver, CO27 अध्ययन
- Rochester, MN24 अध्ययन
- St. Louis, MO24 अध्ययन
- Columbus, OH24 अध्ययन
- Baldwin Park, CA23 अध्ययन
- Chicago, IL22 अध्ययन
Miami में अन्य अध्ययन
- स्तन कैंसर42 अध्ययन
- कैंसर (सभी प्रकार)36 अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर31 अध्ययन
- प्रोस्टेट कैंसर27 अध्ययन
- मोटापा27 अध्ययन
- तीव्र माइलोइड ल्यूकेमिया24 अध्ययन
- मेटास्टेटिक कैंसर24 अध्ययन
- अंडाशय का कैंसर23 अध्ययन
- अधिक वजन23 अध्ययन
- अल्सरेटिव कोलाइटिस21 अध्ययन
- अल्जाइमर रोग20 अध्ययन
- फेफड़ों का कैंसर20 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।